Long‐Term Outcomes of Antithrombotic Treatment in a Cohort of 864 Patients With Fontan Circulation
Open Access
- 21 April 2026
- journal article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (8) , e045788
Abstract
Background: An effective antithrombotic strategy for patients with univentricular heart is required. We determined the prevalence of antithrombotic treatment and survival in patients with Fontan circulation, with secondary outcomes mortality, cardiovascular disease, acute myocardial infarction, and ischemic stroke. Methods: We retrospectively included patients with univentricular heart born in Sweden between January 1, 1970, and December 31, 2017. Data from the National Patient Register, the Cause of Death Register, and the Prescribed Drug Register were used. Patients who underwent total cavopulmonary connection surgery, resulting in Fontan circulation, were included and divided into groups based on treatment: anticoagulation, antiplatelets, and no antithrombotic therapy. Results: In total, 864 patients (median [interquartile range] 14.4 [3.9–24.9] years follow‐up) were included, 511 of whom (59%) were men. Thirty‐six percent received no antithrombotic treatment, and the mortality rate during the follow‐up was 58%. Among the patients treated with antithrombotic treatment, 75% received antiplatelets, with a 4% mortality rate. The mortality incidence rate was 2.40 (95% CI, 1.49–3.67) for antithrombotic treatment and 49.42 (95% CI, 42.50–57.15) without. The hazard ratio for mortality was 22.32 (95% CI, 14.04–35.48) without antithrombotic treatment. The incidence rate of ischemic stroke was 2.45 (95% CI, 1.52–3.75) with antithrombotic treatment and 2.47 (95% CI, 1.13–4.68) without. The incidence rate of acute myocardial infarction was 0.69 (95% CI, 0.25–1.50) with antithrombotic treatment and 2.76 (95% CI, 1.32–5.07) without treatment. Conclusions: Treatment with antiplatelets was associated with lower mortality compared with no antithrombotic treatment.Keywords
This publication has 18 references indexed in Scilit:
- Long-term survival in patients with univentricular heart: A nationwide, register-based cohort studyInternational Journal of Cardiology Congenital Heart Disease, 2024
- Thromboprophylaxis in Patients With Fontan CirculationJACC, 2023
- Coagulation and Anticoagulation in Fontan PatientsCanadian Journal of Cardiology, 2022
- Effect of Aspirin and warfarin therapy on thromboembolic events in patients with univentricular hearts and Fontan palliationInternational Journal of Cardiology, 2013
- Factors Associated With Thrombotic Complications After the Fontan ProcedureJACC, 2013
- 18 Years of the Fontan Operation at a Single InstitutionJACC, 2012
- Predictors of Survival After Single-Ventricle PalliationJACC, 2012
- The Swedish personal identity number: possibilities and pitfalls in healthcare and medical researchEuropean Journal of Epidemiology, 2009
- Clinical Outcome of 193 Extracardiac Fontan PatientsJACC, 2006
- The Validity of a Diagnosis of Heart Failure in a Hospital Discharge RegisterEuropean Journal of Heart Failure, 2005